Fielmann Group AGCHIX:FIED 84 14-Day RSI is 37.66 as of Jul. 12, 2026. GuruFocus rates CHIX:FIED with a GF Score™ of 84/100 and a GF Value™ of €53.82 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Fielmann Group AG ranks better than 92.17% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The industry rank for Fielmann Group AG's 14-Day RSI or its related term are showing as below:
CHIX:FIEd's 14-Day RSI is ranked better than 92.17% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 47.805
vs CHIX:FIEd: 37.66
Fielmann Group AG (CHIX:FIEd) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Fielmann Group AG 14-Day RSI Related Terms
CHIX:FIED vs ISRG, BDX, MDLN: 14-Day RSI Comparison
For the Medical Instruments & Supplies subindustry, Fielmann Group AG's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fielmann Group AG 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fielmann Group AG's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Fielmann Group AG's 14-Day RSI falls into.
Fielmann Group AG (CHIX:FIEd) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fielmann Group AG (CHIX:FIED) has a 14-Day RSI of 37.66 as of Jul. 12, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Fielmann Group AG and its competitors. According to the industry distribution chart, Fielmann Group AG ranks #68 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 7.8%.
Is Fielmann Group AG's 14-Day RSI too high?
Fielmann Group AG's current 14-Day RSI is 37.66. The Medical Devices & Instruments industry median 14-Day RSI is 47.81. Fielmann Group AG's value of 37.66 is 21.2% below this industry median. Based on the distribution chart, Fielmann Group AG ranks #68 out of 868 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Fielmann Group AG has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's 14-Day RSI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fielmann Group AG ranks #68 out of 868 companies for 14-Day RSI. This places Fielmann Group AG in the top 8% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 47.81. Fielmann Group AG's value of 37.66 is 21.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 47.81, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fielmann Group AG's current 14-Day RSI of 37.66 is 21.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Fielmann Group AG and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 47.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current 14-Day RSI is 37.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Based on GuruFocus' analysis, Fielmann Group AG (CHIX:FIED) is currently considered Modestly Undervalued. The stock's GF Value™ is €53.82, compared to a current price of €42.45 — trading 21.1% below its estimated fair value. The current 14-Day RSI is 37.66 and 21.2% below the Medical Devices & Instruments industry median of 47.81. Fielmann Group AG's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Fielmann Group AG (CHIX:FIED), the current 14-Day RSI is 37.66 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fielmann Group AG (CHIX:FIED) Overvalued in 2026?
Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued.
The current stock price of €42.45 is trading 21.1% below its estimated GF Value™ of €53.82.
GuruFocus considers Fielmann Group AG to be Modestly Undervalued.
Key valuation signals for CHIX:FIED:
14-Day RSI: 37.66
GF Value™: €53.82 vs. price of €42.45 (21.1% below fair value)
Industry Position: 21.2% below the Medical Devices & Instruments median (#68 of 868)
No single metric tells the full story. See the CHIX:FIED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
84GF Score
Get the complete analysis for CHIX:FIED
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:FIED has been successfully added to your 